Fobancort Dosage & Drug Information

Concise Prescribing Info

Contents

Per cream Fusidic acid 2%, betamethasone dipropionate 0.05%. Per oint Na fusidate 2%, betamethasone dipropionate 0.05%

Indications/Uses

Inflammatory dermatoses, psoriasis, where bacterial infection caused by Staph & Strep are present or likely to occur.

Dosage/Direction for Use

Apply bd.

Contraindications

Hypersensitivity. Viral skin infections eg, vaccinia, varicella, herpes simplex, TB, acne rosacea, fungal skin infections, perioral dermatitis, ulcerative conditions.

Special Precautions

Discontinue if irritation or sensitization develop. Stasis dermatitis & other skin diseases w/ impaired circulation. Avoid contact w/ eyes. Avoid long-term continuous therapy. Pregnancy & lactation. Childn <2 yr.

Adverse Reactions

Hypersensitivity reactions eg, rashes & irritation, burning, itching, dryness, folliculitis, hypertrichosis, acneiform eruption, hypopigmentation, skin maceration, secondary infection, skin atrophy, striae & miliaria.

View ADR Monitoring Form

MIMS Class

Topical Anti-Infectives with Corticosteroids

ATC Classification

D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Fobancort cream

Packing/Price

15 g x 1's;5 g x 1's

Form

Fobancort oint

Packing/Price

15 g x 1's;5 g x 1's

Fobancort

betamethasone + fusidic acid

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma